Distribution and concordance of PD-L1 expression by routine 22C3 assays in East-Asian patients with non-small cell lung cancer

Distribution and concordance of PD-L1 expression by routine 22C3 assays in East-Asian patients with non-small cell lung cancer

Abstract Background Currently, programmed death ligand-1 (PD-L1) expression has been widely applied in clinical trials and real-world clinical practice as a major biomarker for the efficacy of immune-checkpoint inhibitors. The purpose of this study is to reveal the distribution and concordance of PD...

Full description

Bibliographic Details
Main Authors: Fangqiu Fu, Chaoqiang Deng, Wenrui Sun, Qiang Zheng, Yan Jin, Yuan Li, Yang Zhang, Haiquan Chen
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Respiratory Research
Subjects:
PD-L1
Non-small cell lung cancer
Distribution
Concordance
Online Access:https://doi.org/10.1186/s12931-022-02201-8

Internet

https://doi.org/10.1186/s12931-022-02201-8

Similar Items